Filter by: patients
Home > Community Treatment Reports and Side Effects > Spironolactone-Hydrochlorothiazide Treatment Report
What is Spironolactone-Hydrochlorothiazide?

Antihypertensive agent used in the management of mild-to-moderate hypertension; treatment of edema in congestive heart failure and nephrotic syndrome, and cirrhosis of the liver.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 3 0
Fluid retention weight gain 2 0
Elevated blood pressure 2 0
holding water in leg muscles 1 0
Marfan Syndrome 1 0
Idiopathic Hypercalciuria 1 0

See all 12 patients currently taking Spironolactone-Hydrochlorothiazide

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Spironolactone-Hydrochlorothiazide

Low potassium (hypokalemia) 1

Reported Dosages

  2 daily 25 mg daily 25 mg-25 mg daily 4 x 25 mg-25 mg daily 100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Spironolactone-Hydrochlorothiazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 100%
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Spironolactone-Hydrochlorothiazide

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Spironolactone-Hydrochlorothiazide

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.